https://www.pharmaceutical-technology.com/news/newsmedimmune-receives-fda-fast-track-designation-develop-medi8897-lrti-4551128/ 2015-04-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmarchs-top-stories-salix-sale-valeant-global-drug-development-partnerships-4549254/ 2015-04-09T11:16:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-researchers-develop-new-biochip-device-enhance-drug-discoveries-4550166/ 2015-04-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmylan-acquire-otc-drugmaker-perrigo-29bn-4550183/ 2015-04-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuks-phoremost-collaborates-phylogica-develop-small-molecule-cancer-drugs-4548935/ 2015-04-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroches-avastin-plus-chemotherapy-receives-eu-approval-cervical-cancer-4548948/ 2015-04-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsamgens-vectibix-plus-folfiri-receives-ec-approval-metastatic-colorectal-cancer-4547872/ 2015-04-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbms-uniqure-develop-new-gene-therapies-cardiovascular-diseases-4548085/ 2021-11-22T09:27:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdr-reddys-buy-ucbs-select-product-portfolio-india-4545884/ 2015-04-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscanadas-valeant-buys-salix-11bn-4546022/ 2015-04-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsperrigo-completes-acquisition-otc-drugmaker-omega-pharma-45bn-4544788/ 2015-03-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-jadenu-receives-fda-approval-treat-chronic-iron-overload-4544964/ 2015-03-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsirelands-horizon-pharma-to-buy-hyperion-for-11bn-4543887/ 2015-03-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsisraels-teva-buy-us-based-auspex-35bn-4544046/ 2015-03-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-provide-meningitis-b-vaccine-uk-4542938/ 2015-03-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newschmp-recommends-new-single-pill-combination-therapy-to-treat-type-2-diabetes-4542954/ 2015-03-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-japanese-approval-encruse-ellipta-copd-4541983/ 2023-06-16T04:14:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-orphan-drug-designation-aduro-immuno-oncology-product-candidate-4542041/ 2015-03-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsindias-sun-pharma-completes-32bn-merger-deal-ranbaxy-4541040/ 2015-03-25T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-pasteurs-quadracel-children-4541084/ 2023-06-14T05:43:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-hsci-partner-develop-new-medicines-diabetes-4540002/ 2015-03-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsagios-pyruvate-kinase-deficiency-treatment-receives-fda-orphan-drug-designation-4540093/ 2015-03-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-immunogen-partner-develop-anti-cancer-therapeutics-4539008/ 2015-03-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-and-cshl-develop-new-treatment-obesity-type-2-diabetes-4539023/ 2015-03-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdilaforette-sevuparin-obtains-fda-orphan-drug-designation-treat-scd-4537932/ 2015-03-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newschinas-innovent-eli-lilly-partner-develop-three-new-cancer-treatments-4537947/ 2015-03-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseli-lilly-hanmi-develop-btk-inhibitor-treat-autoimmune-diseases-4536756/ 2023-05-23T03:55:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsevotec-signs-five-year-multi-component-agreement-sanofi-4536931/ 2015-03-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsparp-inhibitors-effective-against-cancer-cells-fault-cblc-gene-says-icr-4535890/ 2015-03-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvertexs-kalydeco-obtains-fda-approval-treat-cf-children-4535986/ 2015-03-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureaddf-2015-overcoming-the-issues-stalling-new-drugs-for-neurodegenerative-diseases-4536384/ 2015-03-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newslupin-acquire-remaining-40-stake-pharma-dynamics-4534227/ 2015-03-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsactavis-acquires-botox-maker-allergan-for-705bn-4535207/ 2015-03-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsemergent-produces-modified-vaccinia-ankara-ebola-zaire-vaccine-candidate-4533026/ 2015-03-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssalix-accepts-valeants-158bn-offer-4533809/ 2015-03-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsactavis-saphris-obtains-fda-approval-to-treat-bipolar-i-disorder-in-paediatric-patients-4532728/ 2022-12-26T12:21:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsawmsg-recommends-sunovions-latuda-treat-schizophrenia-4532897/ 2015-03-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-to-sell-minority-stake-in-south-african-drugmaker-aspen-856m-4531887/ 2015-03-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsepizyme-buys-global-rights-of-ezh2-programme-from-eisai-4531902/ 2015-03-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsendo-proposes-about-11bn-offer-for-drugmaker-salix-4530737/ 2015-03-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdecreasing-ebola-cases-affecting-clinical-trials-says-globaldata-4530924/ 2015-03-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmercks-keytruda-gains-approval-under-uk-eams-treat-advanced-melanoma-4529738/ 2015-03-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-roches-blood-cancer-drug-gazyvaro-treat-cll-4529819/ 2015-03-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfebruarys-top-stories-three-person-ivf-uk-pfizers-purchase-deal-with-hospira-4528677/ 2015-03-10T07:05:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureheadline-bringing-cancers-engine-to-a-halt-4517218/ 2015-03-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsindia-introduces-new-rotavirus-vaccine-4528699/ 2015-03-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscanadas-concordia-to-buy-commercial-assets-of-covis-pharma-for-1-2bn-4528710/ 2015-03-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-accepts-astellas-nda-cresemba-treat-zygomycosis-4527549/ 2023-05-30T04:20:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-sandoz-receives-fda-approval-biosimilar-zarxio-4527616/ 2015-03-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbaxter-buys-german-biopharmaceutical-firm-suppremol-225m-4526393/ 2015-03-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-34-4520130/ 2023-04-12T06:30:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabbvie-to-buy-biopharmaceutical-firm-pharmacyclics-for-21bn-4526184/ 2015-03-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-obtains-ec-approval-pneumococcal-vaccine-prevenar-13-4526201/ 2015-03-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurerethinking-the-role-of-the-placebo-new-trials-test-new-ratios-4517159/ 2022-07-11T08:57:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsec-grants-approval-celgenes-abraxane-treat-nsclc-4524987/ 2015-03-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-acquires-actavis-us-canadian-branded-respiratory-business-600m-4525076/ 2018-11-19T14:52:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssun-pharma-to-acquire-gsks-australian-opiates-business-4524031/ 2015-03-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-completes-20bn-three-part-deal-swiss-novartis-4524071/ 2015-03-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmylan-acquires-abbotts-non-us-specialty-and-branded-generics-business-4522915/ 2015-03-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseu-recommends-roches-avastin-plus-chemotherapy-treat-cervical-cancer-4522988/ 2015-03-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsamarin-eddingpharm-partner-develop-market-vascepa-china-4521889/ 2015-02-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-accepts-amgens-maa-kyprolis-treat-multiple-myeloma-4521961/ 2015-02-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofis-diabetes-treatment-toujeo-obtains-fda-approval-4520878/ 2015-02-25T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-orca-partner-develop-inhibitors-autoimmune-diseases-4521015/ 2015-02-25T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsshire-buys-us-based-meritage-pharma-70m-4519840/ 2022-11-24T12:31:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-mpp-partner-supply-paediatric-hiv-drug-developing-nations-4519853/ 2015-02-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurejapans-pharma-industry-opening-up-to-the-world-4517216/ 2020-09-30T07:15:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbms-to-acquire-biotechnology-firm-flexus-for-125bn-4518780/ 2015-02-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-farydak-obtains-fda-approval-to-treat-multiple-myeloma-4518790/ 2015-02-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsvaleant-buy-us-based-salix-145bn-4517734/ 2015-02-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjapanese-firm-sosei-buys-uk-heptares-therapeutics-400m-4517853/ 2015-02-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscrohns-disease-remsima-could-save-up-to-336m-over-five-years-says-celltrion-4516909/ 2015-02-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscelgenes-revlimid-receives-fda-approval-to-treat-ndmm-4516957/ 2015-02-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-and-lead-pharma-to-develop-treatments-for-autoimmune-diseases-4515868/ 2015-02-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsatyr-pharmas-resolaris-obtains-ema-orphan-drug-designation-treat-fshd-4515939/ 2015-02-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newslupin-celon-pharma-partner-generic-version-gsks-advair-diskus-4514718/ 2015-02-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-to-commercialise-eagles-cancer-drug-in-us-4514791/ 2015-02-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalzheimers-research-uk-launches-three-new-drug-discovery-institutes-4513721/ 2015-02-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshospira-introduces-biosimilar-mab-inflectra-major-european-markets-4513733/ 2015-02-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuremarket-leaders-the-10-most-prescribed-drugs-in-the-us-4508954/ 2023-04-04T08:59:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstpg-to-acquire-actavis-pharmatech-4512592/ 2015-02-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjapans-eisai-receives-fda-expanded-approval-banzel-treat-paediatric-patients-4512617/ 2015-02-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjanssen-launches-new-research-platforms-focus-healthcare-4511647/ 2015-02-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsverastems-vs-5584-obtains-fda-orphan-drug-designation-treat-mesothelioma-4511674/ 2015-02-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-acquires-remaining-stake-swiss-firm-glycovaxyn-190m-4510457/ 2015-02-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvoyager-genzyme-develop-new-aav-gene-therapies-4510719/ 2015-02-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfenex-hospira-develop-lucentis-biosimilar-candidate-4509365/ 2015-02-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmayne-pharma-acquire-us-rights-actavis-doryx-4509645/ 2015-02-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscipla-eu-signs-jv-agreement-morocco-cooper-pharma-phi-4508455/ 2015-02-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssmc-recommends-gsks-anoro-ellipta-bronchodilator-treatment-treat-copd-4508516/ 2015-02-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsks-eltrombopag-seeks-ema-approval-treat-itp-4507338/ 2015-02-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsadimab-and-sanofi-create-new-bispecific-antibody-collaboration-4507365/ 2015-02-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsjanuarys-top-stories-pfizers-deal-with-investors-eli-lillys-buys-novartis-arm-4505110/ 2015-02-06T04:50:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-buy-hospira-17bn-4506018/ 2015-02-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-acquire-actavis-us-canadian-respiratory-business-600m-4506178/ 2018-11-19T14:53:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsindependent-review-calls-more-funding-tackle-drug-resistant-infections-4505164/ 2015-02-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsebola-cases-rise-west-africa-first-time-this-year-who-4505200/ 2015-02-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvaleant-considers-acquisition-us-drugmaker-salix-4504069/ 2023-05-09T07:32:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-mps-vote-in-favour-of-three-person-ivf-technique-4504136/ 2015-02-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsboehringerlillys-glyxambi-receives-fda-approval-for-type-2-diabetes-4502871/ 2023-01-17T10:04:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmylan-acquire-women-health-care-businesses-indias-famy-care-750m-4502883/ 2015-02-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssun-pharma-obtains-us-ftc-approval-32bn-ranbaxy-acquisition-4501691/ 2015-02-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroches-anti-pdl1-receives-fda-breakthrough-therapy-designation-treat-nsclc-4501705/ 2015-02-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjanssen-and-pharmacyclics-receive-fda-approval-for-imbruvica-to-treat-wm-4500688/ 2015-01-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvaleant-to-acquire-us-based-dendreon-296m-4500707/ 2015-01-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-enters-four-research-collaborations-genome-editing-technology-4499621/ 2015-01-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-and-novartis-three-part-transaction-receives-european-approval-4499636/ 2015-01-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsanticholinergic-medications-increase-dementia-risk-says-scientists-4498287/ 2015-01-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-agrees-pay-400m-avoid-investor-class-action-lawsuit-4498513/ 2015-01-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsactavis-buy-uk-auden-mckenzie-306m-4497125/ 2015-01-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbiocrysts-bcx4161-receives-fda-fast-track-designation-treat-hae-4497323/ 2023-03-31T10:38:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-bayers-xarelto-to-reduce-acs-secondary-events-risk-4496043/ 2015-01-25T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgenzyme-cerdelga-gaucher-4495675/ 2015-01-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-lesinurad-gout-4495693/ 2015-01-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-cosentyx-psoriasis-4494565/ 2015-01-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscuris-aurigene-oncology-4494708/ 2015-01-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbaxter-phoxillum-renal-replacement-4493678/ 2015-01-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsboehringer-ingelheim-nintedanib-4493706/ 2015-01-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmsg-urges-gsk-pfizer-reduce-pneumococcal-vaccine-price-developing-nations-4492564/ 2015-01-20T06:38:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurechildhood-cancer-building-on-success-4467902/ 2015-01-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-obtains-european-approval-for-cosentyx-to-treat-psoriasis-4492415/ 2015-01-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabbvie-viekirax-exviera-4491316/ 2015-01-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsneuropore-ucb-parkinsons-4491373/ 2015-01-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdepomed-janssen-nucynta-4490144/ 2015-01-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroche-trophos-4490289/ 2015-01-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-consumer-to-acquire-novartis-otc-business-in-india-for-17m-4489222/ 2015-01-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-adimab-bispecific-antibodies-4488942/ 2015-01-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmersana-takeda-adc-collaboration-4488947/ 2021-11-23T09:24:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbiogen-convergence-4487975/ 2022-07-20T04:07:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroche-foundation-medicine-4488142/ 2015-01-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdaiichi-sankyo-savaysa-4486702/ 2015-01-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsshire-nps-pharma-4486838/ 2015-01-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnew-antibiotic-teixobactin-4485661/ 2015-01-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshelsinn-pharmacosmos-4485674/ 2023-04-05T10:15:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-intellia-caribou-4484769/ 2015-01-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newskhk-syndax-entinostat-4484790/ 2015-01-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature2014-pharmaceutical-technology-4483378/ 2023-05-10T04:20:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-mergers-big-business-bad-science-4467897/ 2022-07-22T05:05:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsamgen-kite-pharma-4483546/ 2015-01-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgilead-phenex-fxr-programme-4483583/ 2015-01-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseli-lilly-novartis-animal-health-4482424/ 2021-10-25T11:44:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-redvax-4482443/ 2015-01-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsrandom-mutations-cancer-research-4481426/ 2015-01-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstxcell-ferring-trizell-4481434/ 2015-01-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbms-opdivo-metastatic-melanoma-4477219/ 2014-12-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbiolinerx-omega-pharma-bl-5010-4477452/ 2014-12-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newslilly-adocia-ultra-rapid-insulin-4475885/ 2014-12-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-eltrombopag-itp-4475906/ 2014-12-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-oncoethix-4474537/ 2014-12-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newslynparza-brca-mutated-ovarian-cancer-4474759/ 2014-12-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-boehringer-ingelheims-pradaxa-to-treat-fatal-blood-clots-in-adults-4473548/ 2014-12-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshalozyme-janssen-to-develop-and-commercialise-subcutaneous-products-4473564/ 2021-11-22T06:48:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-33-4473110/ 2023-04-12T06:42:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspharmaceutical-firms-globaldata-4472639/ 2014-12-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-european-consortium-ebola-4472672/ 2014-12-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmalarial-treatment-synriam-4471331/ 2014-12-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-signifor-lar-4471347/ 2014-12-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-opko-ghd-4470021/ 2014-12-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnanotherapeutics-vero-cell-vaccine-4470175/ 2014-12-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurebetter-together-combining-therapies-to-slow-down-cancer-growth-4454747/ 2014-12-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmdr-tb-compound-4468882/ 2014-12-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfluzone-intradermal-quadrivalent-vaccine-4468962/ 2014-12-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnew-zealand-mylan-abbott-4467242/ 2014-12-12T04:01:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-reserves-sierra-leone-4467272/ 2014-12-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-32-4466494/ 2023-04-12T06:42:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgermany-gvk-biosciences-4466227/ 2014-12-11T05:38:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-dndi-4466251/ 2023-02-06T07:09:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsoutcomes-based-healthcare-4464795/ 2014-12-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssmc-gsk-incruse-ellipta-4464904/ 2014-12-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaurobindo-acquires-natrol-4463419/ 2014-12-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-gene-therapy-4463621/ 2014-12-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovember-top-stories-4460808/ 2014-12-08T06:57:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurecould-zmapps-rapid-approval-set-a-new-precedent-4454675/ 2014-12-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newskkr-significant-minority-stake-arbor-4462179/ 2014-12-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-cubist-pharmaceuticals-4462281/ 2014-12-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsscientists-oxford-university-ebola-4460976/ 2014-12-05T05:33:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-sales-research-jobs-4460966/ 2014-12-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsevotec-sanofi-collaboration-4459474/ 2014-12-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsamgen-blincyto-4459559/ 2014-12-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmylan-gilead-partnership-4458201/ 2014-12-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsotsuka-acquisition-avanir-4458220/ 2014-12-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-marketed-vaccines-portfolio-4456998/ 2014-12-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscancer-research-uk-screening-4455356/ 2014-11-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdaiichi-ucb-biopharma-lacosamide-4455507/ 2021-10-31T15:11:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-nalmefene-to-reduce-alcohol-consumption-4454107/ 2014-11-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnordic-nanovector-and-affibody-to-develop-new-rit-for-multiple-myeloma-4454345/ 2014-11-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjapan-grants-orphan-drug-designation-for-alexions-soliris-to-treat-nmo-4452759/ 2014-11-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-receives-us-ftc-approval-to-acquire-novartis-vaccines-business-4452856/ 2014-11-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuretriple-fixed-doses-improved-insulins-take-centre-stage-at-easd-2014-4449014/ 2023-06-12T03:59:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjanssen-yondelis-sts-4451060/ 2023-07-27T10:07:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseisai-thyroid-cancer-treatment-4451109/ 2014-11-25T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-signifor-acromegaly-4449765/ 2014-11-24T22:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-newlink-genetics-4450071/ 2014-11-24T22:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurenanotech-takes-on-antimicrobial-resistance-4447494/ 2021-04-19T13:55:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabbvie-api-singapore-4448348/ 2014-11-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-duaklir-genuair-4448546/ 2014-11-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdupilumab-fda-breakthrough-therapy-4446953/ 2023-01-23T13:36:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnew-ac-inhibitor-cancer-4447220/ 2014-11-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmymetics-virosome-technology-malaria-4445531/ 2014-11-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsantipsychotic-drug-schizophrenia-4445688/ 2014-11-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsphe-widespread-misconceptions-antibiotics-4444151/ 2014-11-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayers-eylea-japanese-approval-4444181/ 2023-06-19T09:48:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-funding-ebola-research-4442562/ 2014-11-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsactavis-allergan-66bn-4442576/ 2014-11-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-ncds-research-africa-4440412/ 2014-11-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsoligonucleotides-delivery-methods-4440990/ 2014-11-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-contraceptive-sayana-press-4439330/ 2014-11-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbms-programme-viral-diseases-4439352/ 2014-11-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsintarcias-type-2-diabetes-treatment-4437873/ 2014-11-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseltrombopag-severe-aplastic-anaemia-4437905/ 2014-11-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsoral-cholera-vaccine-4436033/ 2014-11-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-ge-healthcare-4436111/ 2014-11-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssmc-bms-daklinza-yervoy-4434429/ 2014-11-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshigh-cholesterol-treatment-evolocumab-4434907/ 2014-11-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaegerion-astrazenecas-lipodystrophy-4432816/ 2023-05-31T05:18:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjohnson-johnson-alios-biopharma-4432833/ 2014-11-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjanssen-union-collaborate-4431560/ 2014-11-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsperrigo-buy-omega-pharma-4431576/ 2014-11-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabide-therapeutics-new-drug-targets-4429861/ 2014-11-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseosinophilic-asthma-drug-4430218/ 2014-11-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastellas-proteostasis-partnership-4428395/ 2014-11-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbms-danish-galecto-biotech-4428424/ 2014-11-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurethe-international-clinical-trials-registry-platform-perils-pitfalls-and-possibilities-4379570/ 2022-07-11T08:57:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspharming-salix-ruconest-4426964/ 2023-03-31T10:38:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-acquires-dihon-4427071/ 2014-11-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbiologics-manufacturing-agreement-4425206/ 2014-11-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsofatumumab-transfer-agreement-4425616/ 2021-12-02T07:48:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizers-trumenba-fda-approval-4423755/ 2014-10-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazenecas-xigduo-xr-fda-4423926/ 2023-05-24T04:15:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsqiagen-astellas-pharma-diagnostics-4420779/ 2014-10-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-incruse-ellipta-uk-4422521/ 2014-10-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsasia-pacific-innovation-center-4420604/ 2014-10-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmercks-keytruda-therapy-designation-4420858/ 2014-10-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsconsortium-economic-models-pharmaceutical-4418927/ 2014-10-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaustralias-csl-novartis-4418959/ 2014-10-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature21st-century-clinical-trial-management-4378902/ 2014-10-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/news230m-new-technologies-research-4417278/ 2014-10-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazenecas-lynparza-ovarian-cancer-4417295/ 2014-10-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsipsen-telotristat-etiprate-4415956/ 2014-10-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroche-invest-3bn-basel-4416011/ 2014-10-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseisais-review-fycompa-4414478/ 2014-10-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjohnson-johnson-200m-ebola-4414497/ 2014-10-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbaxter-hyqvia-us-4413549/ 2014-10-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-bla-review-4413568/ 2014-10-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurehutrial-human-surrogates-for-clinical-trials-becomes-a-reality-4379278/ 2022-07-11T08:57:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsapricus-fispemifene-forendo-4411984/ 2014-10-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsamgen-sues-sanofi-and-regeneron-over-patent-infringement-in-us-4411996/ 2014-10-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-pasteur-immune-design-4410165/ 2014-10-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspharmacyclics-imbruvica-approval-4410184/ 2014-10-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-cambridge-partner-research-4407972/ 2014-10-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsranbaxy-settle-medicaid-4409113/ 2014-10-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsviiv-hiv-triumeq-approval-4406314/ 2014-10-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgenentechs-ipf-treating-drug-esbriet-receives-fda-approval-4407069/ 2014-10-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshelsinns-akynzeo-chemotherapy-4404572/ 2014-10-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newswho-10000-new-ebola-cases-4405379/ 2014-10-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshikma-to-market-eisais-epilepsy-treatment-fycompa-in-middle-east-4403710/ 2014-10-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgileads-harvoni-receives-fda-approval-hepatitis-c-genotype-1-infection-4403828/ 2014-10-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurea-new-era-for-pulmonary-arterial-hypertension-patients-in-england-4379593/ 2023-05-09T07:02:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-uks-adcetris-receives-smc-approval-to-treat-relapsed-or-refractory-cd30-hl-4402480/ 2014-10-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnppa-fines-novartis-india-for-over-pricing-painkiller-voveran-4402690/ 2014-10-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-to-acquire-25-stake-in-aspen-japan-4400827/ 2014-10-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscipla-medpro-to-market-tevas-pharmaceutical-products-in-south-africa-4401272/ 2023-03-14T10:21:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurethe-top-10-biggest-pharmaceutical-companies-of-2014-4396561/ 2024-05-10T07:12:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnabrivas-lefamulin-receives-fda-fast-track-status-to-treat-cabp-and-absssi-4399182/ 2023-05-05T06:54:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsboehringer-brings-striverdi-respimat-to-market-for-copd-treatment-in-us-4399476/ 2014-10-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsemd-serono-icr-and-wellcome-trust-partner-develop-anti-cancer-drugs-4397686/ 2014-10-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsthrombogenics-jetrea-receives-australias-tga-approval-treat-vmt-4397911/ 2014-10-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureseptembers-top-stories-merck-to-buy-sigma-aldrich-gsk-fined-in-china1-4395153/ 2014-10-07T05:34:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuks-medical-research-council-grants-fund-for-three-new-research-programmes-4396012/ 2014-10-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-bms-enter-clinical-collaboration-assess-lung-cancer-treatments-4396026/ 2014-10-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-introduces-new-medicines-optimisation-scratch-card-4394536/ 2014-10-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgrupo-juste-to-supply-da-pharmas-alcover-in-spain-and-central-america-4394549/ 2014-10-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-lundbeck-manufactured-nalmefene-to-help-reduce-alcohol-dependence-4393352/ 2014-10-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-31-4392732/ 2023-04-12T06:30:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurethe-economic-case-for-clinical-trials-10-yr-old-progestin-trial-speaks-volumes-4379126/ 2014-10-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjohnson-johnson-acquire-alios-biopharma-175bn-4392018/ 2014-10-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdaiichi-sankyo-to-buy-ambit-biosciences-for-410m-4391356/ 2014-09-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsafatinib-drug-could-inhibit-growth-womb-cancer-yale-scientists-4391625/ 2014-09-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsamag-pharmaceuticals-buy-lumara-health-675m-4389845/ 2014-09-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsleiden-university-research-team-receives-grant-develop-bladder-cancer-treatment-4389860/ 2014-09-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabbvies-humira-receives-fda-approval-treat-crohns-disease-paediatric-patients-4388079/ 2014-09-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroches-perjeta-breast-cancer-drug-shows-extended-survival-benefit-4388098/ 2014-09-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsrexahns-rx-3117-obtains-fda-orphan-drug-designation-4386405/ 2014-09-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsthermo-fisher-collaborates-gsk-pfizer-develop-ngs-oncology-test-4386415/ 2023-01-25T11:52:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbrazilian-researchers-releases-dengue-blocking-mosquitoes-4384855/ 2014-09-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbaxter-merrimack-partner-develop-nanoliposomal-irinotecan-injection-4384871/ 2014-09-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayers-eylea-receives-japanese-approval-to-treat-myopic-cnv-4383345/ 2014-09-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsstatins-increase-risk-of-type-2-diabetes-bodyweight-say-researchers-4383482/ 2014-09-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-researchers-discover-new-gene-responsible-serious-respiratory-infections-4381641/ 2022-07-28T13:02:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-to-buy-sigma-aldrich-for-17bn-4381678/ 2014-09-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-to-pay-297m-fine-over-bribery-case-in-china-4380245/ 2014-09-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgileads-zydelig-marketing-approval-european-commission-incurable-blood-cancers-4380431/ 2014-09-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssun-pharma-merck-partner-plaque-psoriasis-drug-candidate-tildrakizumab-4378681/ 2014-09-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsboehringer-ingelheim-curevac-develop-lung-cancer-immunotherapy-4378920/ 2014-09-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazenecas-movantik-receives-fda-approval-to-treat-oic-4377157/ 2014-09-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-myokardia-partner-develop-treatments-heritable-heart-diseases-4377406/ 2021-11-22T06:10:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newswarwick-researchers-discover-new-drug-target-to-prevent-postpartum-haemorrhage-4375505/ 2014-09-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmedgenesis-and-pfizer-partner-for-parkinsons-disease-treatments-4375598/ 2014-09-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgilead-signs-licensing-agreements-seven-indian-firms-hepatitis-c-treatments-4374055/ 2014-09-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-seeks-commercial-licence-five-prime-muscle-disease-treatment-4374166/ 2014-09-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsanimal-trials-misguide-drug-discovery-and-development-says-pharmainformatic-4371901/ 2014-09-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-hyqvia-to-treat-primary-immunodeficiency-4372361/ 2014-09-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-orexigen-receive-fda-approval-for-new-weight-loss-pill-4370838/ 2014-09-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmylan-acquire-us-rights-arixtra-225m-4370867/ 2014-09-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuregutsy-new-methods-to-tackle-obesity-4368646/ 2014-09-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgenmab-seattle-genetics-establish-new-antibody-drug-conjugate-collaboration-4369455/ 2014-09-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsebola-outbreak-endangers-national-existence-liberia-defence-minister-4369472/ 2014-09-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureaugusts-top-stories-major-acquisitions-roche-and-meda-ebola-drug-initiatives-4363187/ 2014-09-10T04:16:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscipla-sd-pharma-partner-foray-czech-republic-slovakia-4367633/ 2014-09-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-uk-south-african-research-councils-partner-ncds-africa-4367902/ 2023-06-14T07:02:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-approval-keryx-ferric-citrate-treat-dialysis-patients-hyperphosphatemia-4366065/ 2014-09-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuniversity-toronto-partners-janssen-jj-brain-treatments-4366144/ 2014-09-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmercks-keytruda-receives-fda-approval-to-treat-melanoma-4364734/ 2014-09-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-seeks-approval-leuplin-hormone-dependent-diseases-japan-4364822/ 2014-09-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuremedicalising-marijuana-the-latest-in-cannabinoid-medicine-4359924/ 2014-09-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsinfinity-abbvie-partner-develop-commercialise-duvelisib-cancer-4363381/ 2014-09-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-seeks-marketing-authorisation-of-aflibercept-solution-for-injection-in-japan-4363499/ 2014-09-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsintrexon-sanofi-partner-production-specific-family-apis-4362100/ 2014-09-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsviiv-healthcares-triumeq-hiv-treatment-receives-eu-marketing-authorisation-4362155/ 2014-09-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjapanese-researchers-develop-new-30-minute-method-detect-ebola-virus-4360875/ 2014-09-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscipla-introduces-serroflo-respiratory-treatment-germany-and-sweden-4360899/ 2014-09-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-clears-snda-ucbs-vimpat-anti-epileptic-drug-monotherapy-4359230/ 2014-09-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovo-nordisk-introduces-ryzodeg-mexico-type-2-diabetes-4359290/ 2014-09-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-protalixs-elelyso-receives-fda-approval-treat-type-1-gaucher-disease-4357889/ 2022-11-29T14:38:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsniaid-grants-additional-funding-biocrysts-bcx4430-study-treat-ebola-disease-4357933/ 2014-08-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvifor-pharma-velphoro-receives-eu-marketing-authorisation-treat-hyperphosphatemia-4356727/ 2014-08-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-government-provide-additional-160m-cancer-drugs-fund-4356733/ 2014-08-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-clears-gsks-promacta-snda-to-treat-saa-patients-4356267/ 2022-07-11T08:57:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdarpas-electrx-programme-seeks-to-develop-new-customised-therapies-4356372/ 2014-08-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-orphan-drug-designation-insys-cannabidiol-treat-gbm-4355059/ 2023-01-27T07:48:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvenus-signs-agreement-teva-canada-develop-anti-cancer-drug-4355078/ 2014-08-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroche-to-acquire-intermune-for-83bn-4353577/ 2014-08-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalkermes-submits-new-drug-application-for-aripiprazole-to-treat-schizophreni-4353624/ 2014-08-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-30-4349799/ 2023-04-12T06:42:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscmdh-recommends-restricted-use-of-bromocriptine-to-suppress-lactation-4350580/ 2014-08-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssunovion-introduces-new-oral-treatment-latuda-for-schizophrenia-in-uk-4350704/ 2014-08-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgarvan-roche-to-develop-new-technologies-for-targeted-epigenomic-analysis-4349016/ 2014-08-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-celgenes-revlimid-to-treat-myelodysplastic-syndromes-4349088/ 2014-08-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-launches-new-ebola-research-initiative-4349122/ 2014-08-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-submits-new-drug-application-to-fda-for-breast-cancer-palbociclib-drug-4347528/ 2014-08-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-signs-exclusive-worldwide-licensing-agreement-with-tb-alliance-4347798/ 2014-08-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsawmsg-recommends-bayers-sativex-to-treat-multiple-sclerosis-4346382/ 2014-08-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroches-avastin-plus-chemotherapy-receives-fda-approval-to-treat-cervical-cancer-4345961/ 2014-08-18T04:44:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-biogens-plegridy-to-treat-multiple-sclerosis-4345988/ 2014-08-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmercks-belsomra-receives-fda-approval-to-treat-insomnia-4344916/ 2014-08-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsawmsg-recommends-gsks-relvar-ellipta-to-treat-asthma-4344928/ 2014-08-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-introduces-authorised-generic-version-of-eloxatin-4343920/ 2014-08-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsacip-recommends-pfizers-prevnar-13-to-treat-pneumococcal-disease-in-adults-4344049/ 2014-08-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-grants-orphan-drug-designation-to-miratis-mocetinostat-for-dlbcl-4342609/ 2021-11-25T09:37:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsregenerons-eylea-receives-eu-approval-to-treat-diabetic-macular-edema-4342994/ 2014-08-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-mannkind-partner-to-develop-and-commercialise-afrezza-to-treat-diabetes-4341728/ 2014-08-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-faces-new-claims-of-bribery-in-syria-4341770/ 2014-08-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-rejects-roches-new-breast-cancer-drug-over-high-pricing-4339886/ 2014-08-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsglaxosmithkline-may-start-clinical-trials-ebola-vaccine-next-month-4340431/ 2014-08-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroches-avastin-receives-eu-approval-recurrent-ovarian-cancer-treatment-4338867/ 2014-08-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-grants-orphan-drug-designations-alnylams-aln-at3-hemophilia-treatment-4338904/ 2014-08-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsregulus-biogen-partner-identify-microrna-biomarkers-multiple-sclerosis-4337413/ 2014-08-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnewlink-genetics-contracted-us-dtra-study-ebola-vaccine-4337613/ 2014-08-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabbvies-glioblastoma-multiforme-therapy-receives-orphan-drug-designation-4335836/ 2014-08-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsptcs-translarna-receives-conditional-approval-nonsense-mutation-dmd-eu-4336265/ 2014-08-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalexion-receives-orphan-drug-designation-for-soliris-in-europe-4334024/ 2014-08-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbristol-myers-squibb-and-allied-minds-form-new-research-enterprise-4334575/ 2014-08-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurejuly-top-stories-pfizer-acquire-innopharma-burnet-artes-partner-malaria-vaccine-4335867/ 2014-08-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-india-the-long-road-to-discovery-4331754/ 2022-02-11T04:51:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvertex-obtains-receives-european-approval-for-cystic-fibrosis-oral-medicine-4333343/ 2014-08-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-jardiance-tablets-for-type-2-diabetes-4333484/ 2022-03-15T07:04:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-to-acquire-baxters-portfolio-of-marketed-vaccines-for-635m-4332291/ 2014-07-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmeda-agrees-to-acquire-rottapharm-for-23bn-4332400/ 2014-07-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurethink-tank-why-collaboration-could-hold-the-key-to-alzheimers-cure-4327264/ 2022-12-02T14:45:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-bayers-eylea-treat-diabetic-macular-edema-4331168/ 2022-03-23T09:20:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-to-have-rights-of-almiralls-respiratory-franchise-4331209/ 2021-12-02T09:40:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-committee-recommends-approval-gilead-sciences-zydelig-4328602/ 2014-07-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseuropean-commission-approves-eliquis-deep-vein-thrombosis-pulmonary-embolism-4329974/ 2023-02-10T12:40:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsburnet-artes-partner-to-develop-new-vaccine-malaria-4329040/ 2014-07-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-orphan-drug-designation-to-clementia-pharmaceuticals-palovarotene-4327931/ 2014-07-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newschmp-recommends-pharmacyclics-imbruvica-treat-two-blood-cancers-4327994/ 2014-07-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-gilead-sciences-zydelig-for-three-types-of-blood-cancers-4326215/ 2014-07-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-accepts-alexions-marketing-authorisation-application-for-hypophosphatasia-therapy-4327036/ 2014-07-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsneurotrope-mount-sinai-collaborate-develop-bryostatin-1-npc-disease-4325612/ 2014-07-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-sucampos-amitiza-chronic-idiopathic-constipation-treatment-4325921/ 2014-07-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-researchers-gain-access-deprioritised-pharmaceutical-compounds-4324088/ 2014-07-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssage-therapeutics-receives-fast-track-designation-for-status-epilepticus-therapy-4324543/ 2021-11-23T04:24:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsshire-acquisition-could-save-abbvie-8bn-tax-humira-15-years-globaldata-4323342/ 2014-07-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaduros-pancreatic-cancer-combination-immunotherapy-fda-breakthrough-therapy-designation-4323366/ 2014-07-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscti-biopharma-receives-israeli-approval-aggressive-b-cell-non-hodgkins-lymphoma-therapy-4321986/ 2014-07-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssalix-pharmaceuticals-pharming-receive-fda-approval-for-ruconest-4322007/ 2023-05-09T07:18:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-to-acquire-innopharma-for-360m-4320511/ 2014-07-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-breakthough-therapy-designation-for-intermunes-pirfenidone-4321293/ 2014-07-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-octapharmas-immune-thrombocytopenic-purpura-therapy-4320079/ 2014-07-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmedical-research-council-lead-cross-council-initiative-tackle-antimicrobial-resistance-4320182/ 2014-07-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-priority-review-for-genentechs-cervical-cancer-therapy-4318337/ 2014-07-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsboehringer-ingelheim-launches-anti-dvt-drug-pradaxa-uk-4319047/ 2014-07-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmylan-acquire-non-us-developed-markets-specialty-branded-generics-business-abbott-4318025/ 2014-07-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshealth-canada-approves-sunovions-aptiom-treat-partial-onset-seizures-epilepsy-patients-4318058/ 2014-07-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newszafgens-prader-willi-syndrome-therapy-receives-orphan-drug-designation-in-europe-4316842/ 2023-05-19T04:38:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsprostrakan-to-acquire-archimedes-pharma-for-230m-4316913/ 2014-07-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurejunes-top-stories-75-atlanta-staff-anthrax-mercks-38bn-idenix-pharmaceuticals-4308041/ 2023-01-19T06:42:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbaxter-announces-acquisition-of-aesrx-4315981/ 2014-07-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-accepts-kytheras-atx-101-new-drug-application-4316052/ 2014-07-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsiroko-files-new-drug-application-zorvolex-lebanon-4314274/ 2014-07-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsletrozole-boosts-fertility-women-pcos-says-study-4314880/ 2022-11-30T14:48:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-receives-canadian-approval-nexavar-treat-differentiated-thyroid-cancer-4313077/ 2014-07-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspurdues-hydrocodone-bitartrate-tablets-granted-priority-review-designation-4313765/ 2014-07-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazenecas-forxiga-receives-positive-advice-scottish-medicines-consortium-4312778/ 2014-07-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroche-receives-japanese-approval-for-lung-cancer-therapy-4312795/ 2014-07-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newschmp-recommends-tevaspregnancy-prevention-drug-4310517/ 2014-07-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-theravance-announce-japanese-approval-anoro-ellipta-4311559/ 2014-07-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsforest-laboratories-completes-acquisition-furiex-pharmaceuticals-4310413/ 2014-07-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-genmab-receive-european-approval-for-arzerra-4310804/ 2014-07-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgenentech-to-acquire-seragon-pharmaceuticals-4309089/ 2014-07-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-priority-review-designation-boehringers-idiopathic-pulmonary-fibrosis-therapy-4309364/ 2014-07-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsargentina-approves-genzymes-lemtrada-for-multiple-sclerosis-4307581/ 2014-07-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsipsen-seeks-us-and-european-approvals-for-gastroenteropancreatic-neuroendocrine-tumours-therapy-4308155/ 2022-02-15T08:08:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbristol-myers-squibb-receives-chmps-positive-opinion-eliquis-4306771/ 2014-06-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-theravance-submit-supplemental-new-drug-application-to-fda-for-asthma-drug-4307320/ 2014-06-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsauxilium-enters-definitive-agreement-merge-qlt-4305616/ 2014-06-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgilead-seeks-japanese-clearance-chronic-hepatitis-c-drug-4305731/ 2014-06-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-breakthrough-therapy-designation-boehringers-idarucizumab-4304367/ 2014-06-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssobi-seeks-european-approval-of-xiapex-peyronies-disease-4304607/ 2014-06-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsligand-pharma-tg-therapeutics-sign-licence-agreement-irak-4-inhibitor-programme-4303126/ 2022-08-17T10:57:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-orphan-drug-designation-to-insys-therapeutics-pharmaceutical-cannabidiol-4303148/ 2014-06-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmersana-merck-to-develop-antibody-drug-conjugates-4301175/ 2021-11-23T09:18:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsendo-to-acquire-dava-pharmaceuticals-for-575m-4301786/ 2014-06-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayers-nexavar-receives-japanese-approval-4300422/ 2014-06-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabbott-acquire-russian-pharmaceutical-company-4300736/ 2014-06-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-accepts-cubists-new-drug-application-ceftolozanetazobactam-priority-review-4299127/ 2014-06-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscelsion-completes-acquisition-of-egen-230614-4299438/ 2014-06-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-decides-terminate-prostate-cancer-drug-development-4298335/ 2014-06-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscdc-says-75-atlanta-based-staff-possibly-exposed-to-anthrax-4298616/ 2023-04-04T08:02:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-29-4296791/ 2023-04-12T06:42:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-announces-cancer-immunotherapy-collaboration-with-cellectis-4297380/ 2014-06-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjanssen-enters-licence-agreement-with-vertex-influenza-a-drug-4297402/ 2014-06-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdara-biosciences-receives-fda-orphan-drug-designation-for-krn5500-4295251/ 2014-06-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-submits-biologics-license-application-to-fda-for-meningitis-b-vaccine-4296196/ 2014-06-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnavideas-supplemental-new-drug-application-for-lymphoseek-injection-gets-fda-approval-4294895/ 2014-06-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsagios-receives-orphan-drug-designation-ag-221-treat-acute-myelogenous-leukemia-4294954/ 2014-06-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-gadavist-injection-cleared-breast-cancer-evaluation-4293723/ 2014-06-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-priority-review-for-abbvies-hepatitis-c-therapy-new-drug-application-4293753/ 2014-06-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-signs-licence-agreement-with-synairgen-for-asthma-drug-4292361/ 2014-06-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjanssen-viiv-healthcare-to-develop-two-drug-single-tablet-regimen-for-hiv-1-4292681/ 2014-06-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscottish-medicines-consortium-approves-defitelio-for-haematopoietic-stem-cell-transplantation-4290850/ 2014-06-12T04:11:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-seeks-eu-marketing-approval-aflibercept-solution-injection-treat-macular-edema-4291568/ 2023-07-24T04:00:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsimmunomedics-receives-orphan-drug-designation-for-immu-132-to-treat-pancreatic-cancer-4289336/ 2014-06-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseffrx-pharmaceuticals-receives-fda-orphan-drug-designation-for-ex404-4290237/ 2023-06-05T04:13:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsedisons-vatiquinone-receives-fda-orphan-drug-status-for-leigh-syndrome-4288860/ 2022-11-08T14:05:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-to-acquire-idenix-pharmaceuticals-for-38bn-4289061/ 2014-06-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuredrug-prices-profits-before-patients-4285101/ 2022-07-11T08:57:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmomenta-pharma-receives-fda-orphan-drug-designation-pancreatic-cancer-drug-4287892/ 2014-06-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbiogen-idec-receives-fda-approval-haemophilia-a-drug-4287905/ 2014-06-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-accepts-boehringer-ingelheims-marketing-authorisation-application-for-ipf-drug-4287147/ 2014-06-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseuropean-commission-approves-invega-for-treatment-of-schizophrenia-in-adolescents-4287155/ 2014-06-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-orphan-drug-designation-chemocentryxs-anca-associated-diseases-4285826/ 2014-06-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-agrees-pay-105m-in-asthma-antidepressant-drugs-settlement-4286026/ 2014-06-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurebayers-142bn-acquisition-mercks-consumer-care-akorn-buy-versapharm-4286393/ 2014-06-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-omidria-use-intraoperative-lens-replacement-surgery-4284542/ 2014-06-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-to-acquire-labrys-biologics-for-825m-4284778/ 2014-06-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-fast-track-designation-to-angiochems-glioblastoma-multiforme-drug-4283533/ 2023-01-27T07:47:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-signs-agreement-orion-develop-prostate-cancer-drug-4283631/ 2014-06-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseisais-antiemetic-agent-aloxi-gets-fda-approval-treatment-children-4282476/ 2014-06-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsadaptimmune-gsk-enter-collaboration-ny-eso-1-clinical-cancer-programme-4282512/ 2014-06-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnewron-submits-new-drug-application-to-fda-for-parkinsons-disease-drug-4281517/ 2014-05-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-seeks-japanese-approval-for-xarelto-4281543/ 2014-05-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscelerion-kddf-sign-agreement-advance-drug-discovery-south-korea-4280175/ 2014-05-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbristol-myers-squibb-collaborates-with-cytomx-on-immuno-oncology-targets-4280236/ 2014-05-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsadvaxis-receives-orphan-drug-designation-for-osteosarcoma-immunotherapy-4278955/ 2014-05-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-adopts-positive-opinion-on-octapharmas-haemophilia-a-drug-nuwiq-4278985/ 2014-05-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-may-abandon-69bn-astrazeneca-deal-4276826/ 2014-05-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshealth-canada-approves-janssens-type-2-diabetes-mellitus-medication-4277618/ 2014-05-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsprotalix-gets-marketing-approval-in-australia-for-elelyso-to-treat-gaucher-disease_4275704/ 2014-05-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-orphan-drug-status-inhibikases-imatinib-treat-pml_4275733/ 2014-05-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabbvie-gets-fda-orphan-drug-status-humira-treat-non-infectious-uveitis-4273211/ 2022-12-20T10:38:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjapanese-ministry-grants-orphan-status-to-edisons-epi-743-to-treat-leigh-syndrome-4274458/ 2022-11-08T14:05:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-takedas-entyvio-treat-ulcerative-colitis-crohns-disease-4273277/ 2014-05-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-breakthrough-therapy-status-to-bms-and-abbvies-myeloma-drug-4273293/ 2014-05-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-rejects-final-69bn-takeover-bid-from-pfizer-4271667/ 2014-05-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsshire-plans-seek-fda-approval-dry-eye-drug-early-2015-4272042/ 2014-05-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-fails-secure-fda-approval-heart-failure-drug-serelaxin-4270630/ 2014-05-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseuropean-commission-approves-simeprevir-to-treat-hepatitis-c-genotype-1-and-4-infection-4270689/ 2014-05-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-breakthrough-therapy-status-to-bms-lymphoma-drug-nivolumab-4268420/ 2014-05-16T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsactelions-pah-drug-opsumit-now-available-in-england-4268981/ 2023-05-09T07:11:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsformer-gsk-china-head-accused-of-bribing-doctors-hospitals-4267906/ 2014-05-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-to-review-tevas-snda-for-pediatric-indication-of-qnaslnasal-aerosol-4267970/ 2014-05-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmercks-zontivity-gets-fda-approval-to-reduce-heart-attacks-and-stroke-risk-in-patients-4266810/ 2014-05-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjanssen-submits-sndas-to-fda-for-invega-sustenna-to-treat-schizoaffective-disorder-4266832/ 2023-03-30T07:29:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuresweet-solution-can-honey-help-in-the-fight-against-antibiotic-resistance-4267074/ 2014-05-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayers-kogenate-fs-gets-fda-approval-for-routine-prophylaxis-in-hemophilia-a-patients-4265566/ 2022-07-11T08:58:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsakorn-agrees-to-buy-versapharm-4265713/ 2014-05-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-theravance-announce-european-approval-chronic-obstructive-pulmonary-disease-drug-4263941/ 2014-05-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabbvie-seeks-ema-approval-for-marketing-interferon-free-hepatitis-c-therapy-in-eu-4264466/ 2021-11-22T06:53:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjanssen-submits-snda-to-fda-for-genotype-1-chronic-hepatitis-c-drug-4261950/ 2014-05-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newslundbeck-to-acquire-chelsea-therapeutics-for-658m-4263311/ 2014-05-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-to-review-mercks-biologics-license-application-for-advanced-melanoma-product-4261155/ 2014-05-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizers-takeover-bid-for-astrazeneca-raises-concerns-in-uk-4262124/ 2014-05-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-obtains-fda-approval-for-hypertriglyceridaemia-drug-4259830/ 2014-05-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-acquire-mercks-consumer-care-business-142bn-4260525/ 2014-05-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseuropean-commission-approves-pierre-fabres-hemangiol-for-infantile-hemangioma-treatment-4258458/ 2014-05-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstevas-synribo-for-injection-receives-fda-approval-for-home-administration-4259375/ 2014-05-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureaprils-top-stories-pfizers-60bn-astrazeneca-bid-novartis-gsk-cancer-drugs-acquisition-4259111/ 2014-05-05T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsotsukas-tuberculosis-drug-deltyba-secures-marketing-approval-in-eu-4256475/ 2014-05-02T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsallergans-botox-gets-positive-opinion-from-irish-medicines-board-4256721/ 2014-05-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsusfda-grants-priority-review-for-astrazenecas-ovarian-cancer-drug-olaparib-4255884/ 2014-04-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsks-incruse-ellipta-gets-fda-approval-to-treat-airflow-obstruction-in-copd-patients-4256102/ 2022-07-11T08:58:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnew-subcutaneous-formulation-of-roches-arthritis-drug-roactemra-wins-european-approval-4254802/ 2014-04-30T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseuropean-commission-grants-marketing-approval-for-tevas-duoresp-spiromax-4255071/ 2014-04-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsboehringer-gets-ema-positive-opinion-for-pradaxa-to-treat-dvt-pe-4253593/ 2023-02-10T12:40:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjanssens-type-2-diabetes-drug-vokanamet-gets-european-commission-approval-in-eu-4254729/ 2014-04-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-afatinib-for-treatment-for-lung-cancer-4220475/ 2014-04-28T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsapricuss-erectile-dysfunction-drug-vitaros-gets-national-phase-approval-in-spain-4220857/ 2014-04-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-confirms-60bn-bid-interest-in-astrazeneca-4253951/ 2014-04-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-janssens-sylvant-to-treat-multicentric-castlemans-disease-4220003/ 2014-04-25T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseli-lillys-cyramza-becomes-first-fda-approved-gastric-cancer-drug-4217980/ 2014-04-24T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-orphan-drug-status-to-bayers-bronchiectasis-medicine-ciprofloxacin-dpi-4219218/ 2014-04-24T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvaleant-pershing-square-announce-merger-proposal-with-allergan-4219111/ 2014-04-23T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-may-come-back-to-bid-for-astrazeneca-4219182/ 2014-04-23T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-genmab-obtain-fda-clearance-for-arzerra-as-first-line-treatment-for-cll-4216894/ 2014-04-22T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-to-acquire-gsks-cancer-drugs-for-16bn-4218251/ 2014-04-22T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-28-4216479/ 2023-04-12T06:42:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-limits-approval-for-ferrings-prostate-cancer-drug-firmagon-4215753/ 2014-04-17T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbioalliance-pharma-and-topotarget-join-forces-to-create-new-orphan-oncology-company-4216254/ 2014-04-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-gsks-tanzeum-injection-for-type-2-diabetes-treatment-4215179/ 2014-04-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-obtains-fda-approval-for-grass-pollen-allergy-drug-4215337/ 2023-05-23T03:38:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjanssens-prostate-cancer-drug-zytiga-now-available-in-trinidad-tobago-4214274/ 2014-04-15T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-faces-criminal-investigation-over-bribery-allegations-in-poland-4214761/ 2014-04-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastellas-european-foundation-awards-2014-urology-grant-to-austrian-swiss-researchers-4214969/ 2022-07-20T04:18:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscelladon-gets-fda-breakthrough-therapy-status-mydicar-treat-heart-failure-4213394/ 2014-04-14T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsimpax-pharma-resubmits-nda-to-fda-for-parkinsons-treatment-rytary-4213995/ 2014-04-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstetra-stanley-center-collaborate-to-identify-new-schizophrenia-therapeutics-4212566/ 2014-04-11T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalcobra-submits-protocol-to-us-fda-for-phase-iib-mdx-trial-to-treat-fragile-x-syndrome-4213049/ 2022-12-02T12:25:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspharmacyclics-submits-snda-to-fda-for-leukemia-drug-imbruvica-4211935/ 2014-04-10T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurefull-disclosure-gsk-pledge-open-clinical-trial-data/ 2014-04-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseli-lilly-and-t1d-exchange-partner-to-discover-new-treatments-for-type-1-diabetes-4212351/ 2014-04-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuresharing-clinical-trial-data-responsibly-is-enough-being-done-4212693/ 2014-04-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-priority-review-to-gileads-hepatitis-c-combination-therapy-4211147/ 2014-04-09T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsscottish-medicines-consortium-issues-positive-advice-for-actelions-pah-drug-opsumit-4211402/ 2014-04-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-ferring-and-who-team-up-for-new-anti-bleeding-drug-for-women-after-childbirth-4210439/ 2014-04-08T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmallinckrodt-agrees-to-acquire-questcor-pharmaceuticals-for-56bn-4210901/ 2014-04-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastellas-submits-maa-for-wider-use-of-prostate-cancer-drug-xtandi-in-europe-4209669/ 2014-04-07T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuremicroneedles-the-future-of-pain-free-injections-and-blood-sugar-testing-4207973/ 2018-01-17T17:03:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscritical-outcome-seeks-fda-orphan-drug-status-for-ovarian-cancer-drug-coti-2-4210077/ 2014-04-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalnylam-gets-ema-positive-opinion-for-odd-of-aln-ttrsc-to-treat-attr-patients-4208704/ 2014-04-04T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsapricus-erectile-dysfunction-drug-vitaros-approved-in-luxembourg-4209340/ 2014-04-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsforma-therapeutics-celgene-expand-deal-for-new-therapeutic-areas-4207756/ 2014-04-03T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newserytech-gets-fda-orphan-drug-status-for-ery-asp-to-treat-acute-myeloid-leukemia-4208400/ 2022-02-14T08:45:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsec-approves-bayers-adempas-to-treat-two-forms-of-pulmonary-hypertension-4206973/ 2023-05-09T07:06:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsstallergenes-gets-us-fda-approval-for-allergy-drug-oralair-4207514/ 2023-08-29T04:32:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureclick-to-cure-harnessing-the-power-of-citizen-scientists-4207968/ 2021-11-02T07:03:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsec-approves-marketing-of-dainippon-takedas-schizophrenia-drug-latuda-4206283/ 2021-11-30T11:47:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscytrxs-sarcoma-drug-aldoxorubicin-gets-orphan-medicinal-product-designation-in-europe-4206715/ 2023-01-11T17:16:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsabide-and-celgene-partner-to-develop-new-drugs-4207098/ 2014-03-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroches-lymphoma-drug-mabthera-gets-approval-in-europe-4206201/ 2014-03-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbiogens-hemophilia-b-drug-alprolix-gets-fda-approval-4206213/ 2014-03-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-accepts-avanirs-nda-for-avp-825-to-treat-migraine-4204659/ 2014-03-28T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-validates-gileads-marketing-application-for-hepatitis-c-combination-drug-4205505/ 2014-03-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-actavis-valeants-nda-for-metronidazole-13-vaginal-gel-4203996/ 2023-04-14T09:16:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseuropean-commission-approves-gsks-diabetes-drug-eperzan-4204398/ 2014-03-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsotsukas-samsca-approved-in-japan-for-kidney-disease-4203267/ 2014-03-26T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnew-study-identifies-possible-therapeutic-targets-for-organ-transplantation-4203790/ 2014-03-25T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-celgenes-oral-therapy-otezla-to-treat-psoriatic-arthritis-4202436/ 2014-03-25T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakedas-nda-of-hypertension-drug-zacras-approved-in-japan-4202902/ 2014-03-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-breakthrough-therapy-status-to-pfizer-meningococcal-b-vaccine-4201572/ 2014-03-24T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbiogens-hemophilia-b-therapy-alprolix-approved-in-canada-4202099/ 2014-03-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurecrowdsourced-cancer-research-the-game-is-on-4202376/ 2014-03-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmallinckrodt-acquires-cadence-pharmaceuticals-for-14bn-4200657/ 2014-03-21T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-pasteur-and-sk-chemical-to-jointly-develop-pneumococcal-conjugate-vaccine-4200756/ 2014-03-21T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfive-prime-and-bms-partner-to-discover-new-immuno-oncology-therapies-4198647/ 2014-03-20T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsthrombogenics-vitreomacular-traction-drug-jetrea-gets-approval-in-switzerland-4199592/ 2014-03-20T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-pierre-fabres-pediatric-drug-hemangeol-to-treat-infantile-hemangioma-4198823/ 2014-03-19T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvodafone-astrazeneca-team-up-for-mhealth-patient-services-4198983/ 2022-07-11T08:58:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovo-nordisk-spends-100m-in-new-purification-pilot-facility-in-denmark-4197741/ 2014-03-18T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmercks-noxafil-injection-secures-us-fda-approval-170314-4197993/ 2014-03-18T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbiolinerx-gets-us-patent-covering-use-of-bl-8040-in-immunotherapy-170314/ 2014-03-17T09:05:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstaigens-pneumonia-antibiotic-taigexyn-gets-marketing-approval-in-taiwan/ 2014-03-17T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-receives-clinical-recommendation-in-australia-for-meningitis-b-vaccine/ 2014-03-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-mallinckrodts-pain-drug-xartemis-xr/ 2014-03-14T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-enters-into-partnership-with-uk-government-on-dementia-research/ 2014-03-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstc-biopharm-collaborates-with-medinet-for-new-cancer-immuno-cell-therapy/ 2014-03-13T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsupsher-smiths-antiepileptic-drug-qudexy-xr-gets-fda-approval/ 2014-03-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-introduces-combination-drug-xigduo-in-uk-for-type-2-diabetic-patients-4193995/ 2022-07-11T08:58:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsthrombogenics-receives-3m-grant-from-iwt-for-diabetic-macular-edema-research-4194325/ 2022-12-29T06:53:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-to-work-with-university-college-london-on-muscle-disorder-research-4192344/ 2014-03-11T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-announces-approval-of-adempas-for-pulmonary-arterial-hypertension-treatment-4192921/ 2023-05-09T07:10:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-urticaria-drug-xolair-approved-in-eu-4191727/ 2014-03-10T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsendos-aveed-injectable-replacement-therapy-approved-in-us-to-treat-hypogonadism-4191829/ 2014-03-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseisai-and-biogen-to-develop-new-treatments-for-alzheimers-disease-4190709/ 2014-03-07T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscurie-cancer-dna-therapeutics-to-combat-cancers-that-resist-conventional-therapies-4191172/ 2014-03-07T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstracon-and-santen-partner-to-develop-trc105-in-ophthalmology-4189752/ 2014-03-06T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsforest-laboratories-submits-nda-to-fda-for-combination-drug-to-treat-alzheimers-disease-4189981/ 2014-03-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-gets-fda-approval-for-bydureon-pen-to-treat-type-2-diabetes-4188900/ 2014-03-05T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurejanssen-biotechs-leukaemia-drug-4189138/ 2014-03-05T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-seeks-japanese-approval-for-vegf-trap-eye-to-treat-diabetic-macular-edema-4189149/ 2023-07-24T04:00:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgw-pharma-gets-fda-orphan-status-for-epidiolex-to-treat-lennox-syndrome-4188163/ 2021-11-22T07:38:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabide-celgene-to-advance-treatment-paradigm-for-patients-with-immune-disorders-4188251/ 2014-03-04T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsthe-medicines-companys-cssti-treatment-oritavancin-approved-in-europe-4186903/ 2014-03-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsignyta-files-ind-application-with-fda-for-oral-tyrosine-kinase-inhibitor-4186934/ 2014-03-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-anikas-osteoarthritis-drug-monovisc-4186059/ 2014-02-28T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-to-acquire-chinese-otc-drug-maker-dihon-280214-4186537/ 2014-02-27T23:38:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgaldermas-mirvaso-gets-ec-approval-for-treatment-of-rosacea-4186301/ 2022-11-29T15:41:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-accepts-biocryst-pharmaceuticalss-nda-application-for-intravenous-peramivir-4185227/ 2014-02-27T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-grants-orphan-drug-status-to-immunocellular-ict-107-for-glioblastoma-4185271/ 2014-02-27T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsiroko-pharmaceuticals-pain-drug-tivorbex-gets-fda-approval-4184040/ 2014-02-26T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-astrazenecas-myalept-to-treat-lipodystrophy-4184950/ 2023-05-30T03:31:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjapanese-authorities-approve-genentech-novartis-dme-drug-lucentis-4183133/ 2014-02-25T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-breakthrough-designation-to-bmss-dcv-dual-regimen-for-hcv-patients-4183611/ 2014-02-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-panel-issues-positive-opinion-for-biomarin-morquio-a-syndrome-drug-vimizim-4182145/ 2014-02-24T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnuevolution-enters-into-drug-discovery-agreement-with-mercks-subsidiary-4182798/ 2014-02-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-accepts-mdcos-nda-for-oritavancin-with-priority-review-4181325/ 2014-02-21T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-panel-issues-positive-opinion-for-copd-drugs-anoro-and-incruse-4181897/ 2014-02-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-27-4188942/ 2023-04-12T06:42:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-to-review-navideas-lymphoseek-snda-in-head-and-neck-cancer-4180689/ 2014-02-20T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsactavis-to-buy-forest-laboratories-for-25bn-4181110/ 2014-02-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscellectis-and-servier-partner-to-develop-new-products-targeting-solid-tumours-4179637/ 2014-02-19T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newschelsea-gets-fda-approval-for-northera-to-treat-patients-with-symptomatic-noh-4180362/ 2022-07-11T08:58:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-panel-rejects-expanded-use-of-bayer-and-janssens-xarelto-in-acs-patients-4178852/ 2014-02-18T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssamyang-to-distribute-bmg-pharmas-gelx-in-south-korea-4179423/ 2014-02-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalvogen-and-hospira-launch-mab-therapy-inflectra-in-central-eastern-europe-4178295/ 2014-02-17T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbiomarins-vimizim-gets-fda-approval-to-treat-morquio-a-syndrome-patients-4178631/ 2022-07-11T08:58:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjanssen-biotechs-leukemia-drug-imbruvica-gets-fda-approval-4177514/ 2014-02-14T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshealth-canada-approves-otsuka-and-lundbecks-schizophrenia-drug-abilify-maintena-4177802/ 2014-02-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshealth-canada-approves-celgenes-progressive-multiple-myeloma-drug-pomalyst-4176495/ 2014-02-13T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseuropean-universities-and-companies-partner-in-85m-antibiotics-development-project-4177081/ 2014-02-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshealth-canada-approves-aegerions-juxtapid-for-hofh-treatment-4175585/ 2023-04-14T07:58:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmallinckrodt-to-buy-cadence-pharmaceuticals-for-13bn-4176140/ 2014-02-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsrecordati-to-market-apricus-vitaros-in-spain-russia-turkey-and-other-global-territories-4175031/ 2014-02-11T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgilead-submits-nda-of-ldvsof-combination-tablet-to-treat-genotype-1-hepatitis-c-in-us-4175412/ 2014-02-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-accepts-of-spectrum-pharmas-nda-filing-of-peripheral-t-cell-lymphoma-drug-beleodaq-4173647/ 2014-02-10T00:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalcobra-submits-inda-application-to-fda-for-extended-release-metadoxine-for-adhd-patients-4174547/ 2014-02-09T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureblue-angel-darpas-vaccine-manufacturing-challenge-4171658/ 2014-02-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsomeros-oms824-gets-fda-fast-track-status-for-huntingtons-disease-programme-4173018/ 2023-05-09T06:46:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsrempex-secures-90m-barda-contract-to-support-gram-negative-antibiotic-development-4173174/ 2014-02-07T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-breakthrough-therapy-status-to-gsks-aplastic-anaemia-drug-eltrombopag-4172103/ 2014-02-06T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgenzyme-multiple-sclerosis-drug-lemtrada-gets-mexican-approval-4172559/ 2014-02-06T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurethe-numbers-game-boosting-clinical-trial-enrolment-4171654/ 2022-07-11T08:58:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbiogen-multiple-sclerosis-drug-tecfidera-approved-in-eu-4171598/ 2014-02-05T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsks-tafinlar-now-available-in-england-for-melanoma-treatment-4172354/ 2014-02-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsedison-and-dainippon-sumitomo-enter-into-43bn-drug-development-deal-4170391/ 2014-02-04T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-test-copy-4169800/ 2014-02-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuniversity-of-edinburgh-and-selcia-partner-to-develop-new-drugs-for-sleeping-sickness-4170854/ 2014-02-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsavanir-files-new-drug-application-to-fda-for-avp-825-to-treat-migraine-patients-4169629/ 2014-02-03T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-vandas-hetlioz-to-treat-sleep-disorder-in-totally-blind-people-4169984/ 2014-02-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsquest-and-oncovir-to-evaluate-combinatorial-immunotherapy-clinical-trial-for-ovarian-cancer-4168841/ 2022-07-11T08:58:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbaxter-restructures-existing-licence-deal-with-xenetic-biosciences-4169271/ 2014-01-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-and-transgene-start-construction-of-new-bioproduction-platform-in-france-4167981/ 2014-01-30T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-grants-orphan-drug-status-to-octreopharms-ops202-to-manage-neuroendocrine-tumours-4168502/ 2014-01-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnibio-aeras-and-create-enter-into-tb-vaccines-development-deal-4166937/ 2014-01-29T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstevas-copaxone40mgml-gets-fda-approval-for-treatment-of-multiple-sclerosis-4167575/ 2014-01-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsks-type-2-diabetes-drug-eperzan-moves-toward-approval-in-europe-4166172/ 2014-01-28T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-panel-issues-positive-opinion-for-dsp-takedas-schizophrenia-drug-lurasidone-4166741/ 2014-01-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsapricus-gets-national-phase-approval-in-belgium-for-erectile-dysfunction-cream-vitaros-4165140/ 2014-01-27T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-secures-eu-panel-backing-for-riociguat-to-treat-two-forms-of-pulmonary-hypertension-4165884/ 2023-05-09T07:07:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-and-bmss-type-2-diabetes-drug-xigduo-gets-marketing-authorisation-in-eu-4164438/ 2014-01-24T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-orphan-drug-status-to-biolinerxs-bl-8040-for-stem-cell-mobilisation-treatment-4165050/ 2014-01-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalexions-soliris-gets-fda-orphan-drug-status-for-prevention-of-dgf-in-renal-transplant-patients-4163839/ 2023-04-06T09:54:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuks-icr-and-crt-enter-drug-discovery-collaboration-with-nuevolution-for-cancer-treatment-4164239/ 2014-01-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-starts-takeover-offer-for-all-shares-of-algeta-for-21bn-4162942/ 2014-01-22T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssantheras-raxone-gets-french-approval-for-treatment-of-lebers-hereditary-optic-neuropathy-4163512/ 2021-12-01T12:36:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjapans-mhlw-approves-nda-of-adcetris-to-treat-malignant-lymphoma-4161857/ 2014-01-21T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmexican-regulatory-panel-approves-aegerions-juxtapid-capsules-to-treat-hofh-patients-4162707/ 2014-01-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-panel-votes-against-expanded-use-of-bayer-jjs-xarelto-in-acs-patients-4161098/ 2014-01-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmundipharma-acquires-patents-for-heroin-substitution-from-phoenux-4162002/ 2014-01-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmgh-broad-amgen-collaboration-to-develop-new-inflammatory-bowel-disease-drugs-4160815/ 2014-01-17T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newszealand-pharma-sanofi-to-start-first-lixilan-phase-iii-trial-in-q1-2014-4161130/ 2014-01-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-accepts-new-drug-application-for-gileads-lymphoma-drug-idelalisib-4160090/ 2014-01-16T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-accepts-to-review-irokos-zorvolex-snda-to-treat-osteoarthritis-pain-in-adults-4160650/ 2023-06-27T04:12:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgenzyme-and-alnylam-expand-agreement-to-develop-new-treatments-for-rare-genetic-diseases-4159518/ 2014-01-15T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newschelsea-therapeutics-symptomatic-noh-drug-secures-fda-panels-backing-4159822/ 2014-01-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-astrazeneca-and-bms-diabetes-drug-farxiga-4159237/ 2023-05-24T04:22:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-and-regeneron-to-develop-new-antibody-to-treat-eye-diseases-4159467/ 2014-01-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbiogen-idec-sangamo-to-develop-new-treatments-for-hemoglobinopathies-4158658/ 2014-01-13T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalnylam-buys-mercks-sirna-therapeutics-4159001/ 2014-01-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-to-accelerate-review-of-bristol-myers-squibbs-hcv-drug-daclatasvir-4157889/ 2014-01-10T01:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsks-mekinist-tafinlar-combination-gets-fda-approval-for-melanoma-treatment-4158335/ 2014-01-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsec-approves-abraxane-plus-gemcitabine-to-treat-metastatic-pancreatic-cancer-4157176/ 2014-01-09T06:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbiolinerx-and-jhl-biotech-to-develop-type-1-diabetes-antibody-treatment-4157698/ 2014-01-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscapricor-and-janssen-to-develop-new-cardiovascular-products-4156540/ 2014-01-08T06:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshorizon-and-astrazeneca-partner-for-development-of-new-cancer-drugs-4156906/ 2014-01-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuregenovate-and-scinopharms-new-hepatitis-b-drug-european-approval-for-bayers-xofigo-4155754/ 2014-01-07T06:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastellas-clearpath-partner-for-new-vaccines-targeting-infectious-diseases-4155672/ 2018-11-19T14:54:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-fast-track-status-to-peregrines-nsclc-drug-bavituximab-4156341/ 2014-01-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsregenerx-gets-fda-orphan-drug-status-for-t4-to-treat-neurotrophic-keratopathy-patients-4155377/ 2022-07-11T08:58:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfit-biotech-to-start-trial-of-possible-hiv-vaccine-in-2014-4155309/ 2014-01-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsagilis-and-intrexon-to-develop-dna-based-therapeutics-for-rare-genetic-disease-4154394/ 2014-01-03T05:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvaxenta-files-international-patent-for-unique-cancer-immunotherapy-treatment-4154496/ 2014-01-03T05:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-accepts-cubists-tedizolid-phosphate-nda-4153834/ 2014-01-02T06:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssenesco-signs-letter-of-intent-to-merge-with-fabrus-4153853/ 2014-01-02T06:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroches-rheumatoid-arthritis-drug-roactemra-gets-chmp-positive-opinion-4150372/ 2013-12-24T06:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsks-cervarix-two-dose-schedule-gets-marketing-authorisation-in-europe-4150486/ 2013-12-24T06:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-to-acquire-exclusive-rights-to-develop-natrogens-natura-alpha-compound-4149764/ 2013-12-23T06:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-baxters-feiba-to-treat-hemophilia-ab-patients-with-inhibitors-4149814/ 2013-12-23T06:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-and-theravance-secure-fda-approval-for-copd-drug-anoro-ellipta-4149089/ 2013-12-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsregeneron-gets-fda-acceptance-of-eylea-injection-for-diabetic-macular-edema-indication-4149331/ 2022-11-25T16:59:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-committee-recommends-athersys-allogeneic-therapy-to-treat-gvhd-4148595/ 2013-12-19T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-and-cnio-enter-license-deal-for-novel-cancer-drug-development-4148905/ 2013-12-19T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-26-4147854/ 2023-04-12T06:35:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgileads-chronic-hepatitis-c-drug-sovaldi-gets-notice-of-compliance-from-health-canada-4147773/ 2013-12-18T06:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnavidea-seeks-fda-approval-for-lymphoseek-injection-to-treat-head-and-neck-cancer-patients-4148329/ 2013-12-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgileads-hiv-1-regimen-complera-gets-fda-approval-4147101/ 2013-12-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgrnenthal-and-acelrx-partner-for-commercialisation-of-zalviso-in-eu-4147342/ 2013-12-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspharmaceutical-technologycom-launches-major-industry-survey-4147845/ 2013-12-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-panel-supports-astrazeneca-and-bms-metreleptin-for-generalised-lipodystrophy-4145816/ 2023-05-31T05:18:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgenzymes-multiple-sclerosis-drug-lemtrada-obtains-canadian-approval-4146108/ 2013-12-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-to-spend-200m-in-uk-manufacturing-facilities-4144771/ 2013-12-13T06:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgreer-laboratories-grass-pollen-allergy-drug-oralair-gets-fda-advisory-committee-support-4145611/ 2023-08-29T04:32:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbaxter-seeks-fda-approval-of-obi-1-to-treat-adults-with-acquired-hemophilia-a-4143946/ 2013-12-12T06:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroche-and-prothena-to-jointly-develop-and-promote-antibodies-to-treat-parkinsons-disease-4144997/ 2013-12-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsproteostasis-enter-deal-with-biogen-idec-for-new-therapies-for-neurodegenerative-diseases-4143636/ 2013-12-11T06:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsscottish-medicines-consortium-approves-onglyza-for-triple-therapy-for-type-2-diabetes-patients-4144030/ 2013-12-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbaxter-seeks-fda-approval-of-rixubis-in-pediatric-hemophilia-b-patients-4143322/ 2022-07-11T08:58:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsanakinra-licensed-in-uk-to-treat-caps-in-infants-and-adults-4142871/ 2013-12-10T06:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdyax-gets-fda-orphan-drug-status-for-hae-drug-dx-2930-4142021/ 2013-12-09T06:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazenecas-influenza-vaccine-fluenz-tetra-gets-marketing-authorisation-in-europe-4142537/ 2013-12-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-grants-orphan-drug-status-to-immunomedics-immu-132-for-sclc-therapy-4141411/ 2013-12-06T06:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbioalliance-gets-us-german-approval-to-begin-phase-iii-relive-trial-in-primary-liver-cancer-4141800/ 2013-12-06T04:46:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbaxter-files-modified-bla-to-fda-for-hyqvia-to-treat-primary-immunodeficiency-4139964/ 2013-12-05T06:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newskinex-pharma-gets-fda-orphan-drug-status-for-gliomas-drug-kx02-4141132/ 2013-12-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsoncomed-celgene-to-develop-new-multiple-anti-cancer-stem-cell-therapeutics-4140662/ 2013-12-04T13:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdurata-therapeutics-files-marketing-authorization-application-for-dalbavancin-in-europe-4140339/ 2023-03-20T15:43:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseisai-seeks-indication-expansion-for-pariet-in-japan-4139494/ 2013-12-02T13:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsconatuss-chronic-liver-disease-treatment-emricasan-gets-fda-orphan-drug-status-4139697/ 2022-09-01T13:26:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbayer-seeks-japanese-approval-for-vegf-trap-eye-for-treatment-of-myopic-cnv-4139229/ 2013-12-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsvifor-pharmas-hyperphosphatemia-drug-velphoro-gets-fda-approval-4139456/ 2013-12-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurejohnson-johnson-jj-and-subsidiaries-janssen-pharmaceuticals-4142239/ 2013-12-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgw-pharmaceuticals-obtains-swiss-approval-for-sativex-4139633/ 2021-12-02T09:40:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-obtains-fda-approval-for-noxafil-delayed-release-tablets/ 2013-11-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-big-pharma-ethics-of-tv-advertising/ 2020-01-31T13:50:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsvbl-therapeutics-gets-fda-fast-track-status-glioblastoma-multiforme-drug/ 2023-01-27T07:48:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsportola-gets-fda-breakthrough-therapy-status-for-andexanet-alfa/ 2013-11-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseuropean-commission-funds-new-alliance-to-combat-poverty-related-diseases/ 2013-11-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsjanssen-obtains-fda-approval-olysio-combination-therapy-hepatitis-c-treatment/ 2013-11-25T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-obtains-fda-approval-bird-flu-vaccine/ 2013-11-25T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-obtains-regular-fda-approval-for-xalkori-for-treatment-of-alk-positive-nsclc/ 2013-11-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsviiv-healthcare-obtains-european-positive-opinion-for-hiv-drug-tivicay/ 2013-11-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgenzyme-gets-health-canada-approval-for-multiple-sclerosis-drug-aubagio/ 2013-11-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsamicus-obtains-global-rights-investigational-fabry-disease-drug/ 2023-05-22T07:21:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsq-therapeutics-gets-fda-orphan-drug-status-for-q-cells-treat-als-patients/ 2013-11-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-biopharm-sign-co-research-agreement-develop-arthritis-drug/ 2013-11-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmercks-nda-intravenous-noxafil-gets-fda-priority-review-status/ 2013-11-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-approving-cancer-drugs-uk-nhs-cost/ 2013-11-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-accepts-astrazenecas-new-drug-application-constipation-drug/ 2023-02-14T09:32:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-and-theravance-obtain-european-approval-relvar-ellipta/ 2013-11-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newslumena-receives-positive-comp-opinion-orphan-drug-designation-liver-drug/ 2013-11-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbayer-gets-european-marketing-authorisation-for-cancer-drug-xofigo/ 2013-11-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-serono-to-invest-80m-in-new-chinese-manufacturing-facility/ 2013-11-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsboehringer-seeks-european-approval-for-expanded-indication-of-tiotropium-respimat/ 2013-11-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsapricus-majorelle-sign-pact-market-erectile-dysfunction-cream-vitaros/ 2013-11-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsshield-therapeutics-submits-ind-application-for-phase-iii-trial-of-iron-replacement-therapy/ 2013-11-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspharmacyclics-gets-fda-approval-for-lymphoma-drug-imbruvica/ 2013-11-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-trace-metals-pharmaceuticals-impurity/ 2013-11-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnanoviricides-denguecide-gets-ema-orphan-drug-status/ 2013-11-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbayers-eye-drug-eylea-wins-canadian-approval-for-wet-amd-treatment/ 2013-11-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgenovate-scinopharm-jointly-develop-new-hepatitis-b-drug/ 2013-11-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-to-spend-120m-new-cancer-drug-manufacturing-facility/ 2013-11-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbayer-seeks-european-approval-for-new-use-of-eye-drug-eylea/ 2013-11-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssunovions-aptiom-gets-us-approval-once-daily-adjunctive-treatment-partial-onset-seizures/ 2013-11-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsneopharm-to-market-prima-biomeds-ovarian-cancer-drug-in-israel/ 2013-11-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssalix-buy-santarus-for-26bn/ 2013-11-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsadvaxis-cancer-vaccine-gets-fda-orphan-status-treatment-hpv-associated-head-neck-cancer/ 2023-01-04T11:33:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsjohnson-johnson-pay-2bn-settle-false-drug-marketing-allegations/ 2013-11-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroche-licenses-antibiotic-pol7080-from-polyphor/ 2013-11-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-predict-control-open-source-disease-modelling-ibm/ 2013-11-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsaeterna-zentaris-files-nda-macimorelin-acetate-us/ 2013-11-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbristol-myers-squibb-files-nda-in-japan-for-all-oral-hepatitis-c-treatment/ 2013-11-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmundipharma-unveils-four-abstracts-of-health-economic-studies/ 2013-11-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsstem-cell-therapeutics-obtains-fda-orphan-drug-status-leukaemia-drug/ 2013-11-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroches-gazyva-combination-vaccine-gets-fda-approval-treat-cll-patients/ 2022-07-11T08:58:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscytodyn-files-revised-protocol-to-fda-for-phase-iib-study-of-hiv-drug/ 2021-11-26T05:25:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-octobers-top-stories-viiv-healthcare-european-application-hiv-tablet/ 2013-10-31T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbaxter-seeks-european-approval-for-recombinant-factor-ix-therapy/ 2013-10-31T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscempras-taksta-secures-fda-orphan-drug-status-prosthetic-joint-infections-treatment/ 2023-01-04T09:54:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsjanssen-seeks-european-approval-for-leukaemia-drug-ibrutinib/ 2013-10-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdepomed-launches-lazanda-nasal-spray-treatment-breakthrough-cancer-pain/ 2013-10-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-gates-foundation-partner-heat-stable-adjuvants-vaccines/ 2013-10-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-panel-recommends-gileads-sofosbuvir-combination-therapy-hepatitis-c-patients/ 2013-10-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newslundbeck-secures-us-fda-approval-for-expanded-indication-of-epilepsy-drug/ 2013-10-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-panel-recommends-simeprevir-combination-therapy-treatment-hepatitis-c-patients/ 2013-10-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsviiv-healthcare-submits-european-application-three-drug-hiv-tablet/ 2013-10-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsallergans-vistabel-obtains-positive-opinion-from-ansm-to-treat-crows-feet-lines/ 2013-10-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsalexion-obtains-fda-breakthrough-therapy-status-for-cpmp-to-treat-mocd-type-a-disorder/ 2013-10-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-25/ 2023-04-12T06:33:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsamgen-acquires-sales-rights-roches-neupogen-neulasta-100-markets/ 2013-10-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbiolinerx-signs-licensing-deal-with-israeli-institutions-for-type-1-diabetes-treatment/ 2013-10-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspdl-biopharma-secures-rights-to-diabetes-royalties-milestones-depomed/ 2013-10-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsviiv-healthcare-files-new-drug-application-for-three-drug-hiv-pill-with-us-fda/ 2013-10-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsablynx-grants-license-eddingpharm-anti-rankl-nanobody-development-greater-china/ 2013-10-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsranbaxy-obtains-approval-market-malaria-drug-india/ 2013-10-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbayer-gets-health-canada-approval-for-treatment-of-gist-with-stivarga/ 2013-10-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-and-genmab-seek-fda-approval-ofatumumab-combination-therapy-first-line-treatment-cll/ 2013-10-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-bioprinting-regenerative-revolution-technology/ 2013-10-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-gets-european-approval-for-label-update-of-pneumococcal-conjugate-vaccine-prevenar-13/ 2013-10-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsaltherx-obtains-us-patent-for-solabegron-combination-therapy-for-oab-treatment/ 2013-10-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsimmatics-secures-34m-financing-completing-phase-iii-development-renal-cancer-vaccine/ 2013-10-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsisis-receives-milestone-payment-from-biogen-idec-for-advancement-of-dystrophy-drug/ 2013-10-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsantares-otrexup-injection-gets-us-fda-approval/ 2013-10-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsjanssen-seeks-ema-approval-fixed-dose-combination-hiv-medicine-darunavir-cobicistat/ 2013-10-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-janssen-jointly-promote-prostate-cancer-treatment-japan/ 2013-10-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsboehringer-files-european-marketing-authorisation-application-lung-cancer-drug/ 2013-10-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsalkermes-obtains-us-fda-fast-track-status-for-depression-drug/ 2013-10-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsauxilium-market-vivus-erectile-dysfunction-drug-us-canada/ 2013-10-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgilead-sciences-stop-phase-iii-study-leukemia-drug/ 2013-10-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssihuan-pharmas-clinical-study-application-oncology-drug-pirotinib-accepted-cfda/ 2013-10-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsallegro-gets-fda-approval-start-two-phase-ii-trials-integrin-peptide-therapy/ 2023-01-24T16:05:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsworld-health-organization-approves-new-japanese-encephalitis-vaccine/ 2013-10-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-colombia-successful-quest-to-cure-river-blindness/ 2023-02-06T07:08:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseleison-obtains-eu-orphan-drug-designation-osteosarcoma-drug/ 2013-10-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newskeryxs-nda-kidney-drug-accepted-filing-us-fda/ 2013-10-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-fda-accepts-ligands-ind-application-diabetes-drug/ 2013-10-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgt-biologics-obtains-fda-orphan-drug-designation-for-paediatric-crohns-drug/ 2013-10-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-secures-fda-approval-for-hot-flashes-drug-duavee/ 2013-10-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdiscovery-labs-gets-fda-approval-for-updated-product-specifications-of-infant-respiratory-drug/ 2013-10-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsboehringer-to-shut-down-manufacturing-lab-eliminating-1100-jobs/ 2013-10-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-and-genmab-seek-alternative-approval-leukaemia-drug-arzerra/ 2013-10-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-developing-personalised-medicines-penn-state-university/ 2013-10-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsaerial-biopharma-announce-positive-phase-ii-results-narcolepsy-drug/ 2013-10-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnatural-killer-research-wins-inaugural-astellas-urooncology-grant/ 2013-10-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-september-stories-roche-injectable-herceptin-generic-xeloda-colon-cancer/ 2013-10-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-calico-google-ageing-process-healthcare/ 2023-01-19T06:39:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscommon-blood-pressure-drug-could-help-fight-tumours/ 2013-10-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsglobal-virus-network-calls-for-more-research-as-us-measles-cases-surge/ 2013-10-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsglaxosmithkline-to-sell-thrombosis-brands-to-aspen/ 2013-09-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsanida-pharma-receives-parkinsons-grant-from-michael-j-fox-foundation/ 2013-09-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuks-cancer-drug-fund-extended-to-2016/ 2013-09-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsboehringer-ingelheim-cancer-drug-shows-positive-results-in-phase-iii-trial/ 2013-09-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-cancer-study-group-co-fund-research-new-cancer-treatment/ 2013-09-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsramucirumab-misses-endpoint-for-breast-cancer-proves-effective-gastric-cancer/ 2013-09-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-treating-type-two-diabetes-century-pandemic/ 2013-09-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovel-brain-cancer-drug-shows-positive-signs-in-phase-1-clinical-trial/ 2013-09-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbayers-hypertension-drug-granted-orphan-drug-designation-by-fda/ 2013-09-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstype-2-diabetes-linked-anti-depressant-use/ 2013-09-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-fda-refuses-approve-mercks-selective-relaxant-binding-agent/ 2013-09-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-china-sales-may-take-30-hit-due-to-bribery-scandal/ 2013-09-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-hepatitus-c-treatment-granted-additional-indication-in-europe/ 2013-09-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-market-insight-patent-cliff-fertile-environment-generics/ 2013-09-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscientists-close-to-developing-universal-flu-vaccine/ 2013-09-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsucsd-researchers-develop-new-antibiotics-detection-technique/ 2013-09-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-signs-deal-with-barda-for-anti-anthrax-medication/ 2013-09-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspharma-companies-release-survey-results-showing-britons-better-access-new-cancer-drugs/ 2013-09-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-bioelectronic-medicine-body-electrical-language-gsk/ 2013-09-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseuropean-commission-gives-marketing-approval-prostate-cancer-drug/ 2013-09-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovartis-investigating-eye-care-unit-bribery-claims-china/ 2013-09-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-first-generic-xeloda-colon-cancer/ 2013-09-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmultiple-sclerosis-treatment-endorsed-ema/ 2013-09-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-bans-use-any-drugs-made-ranbaxy-facility-mohali-india/ 2013-09-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgenzymes-multiple-sclerosis-treatment-approved-by-european-commission/ 2013-09-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshuman-study-discovers-vital-information-h1n1-influenza-virus/ 2022-12-02T14:29:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscolumbia-laboratories-acquires-uk-pharma-developer/ 2013-09-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newschinese-authorities-probe-bayer-domestic-drug-companies/ 2021-10-27T12:49:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgeneric-versions-high-cholesterol-drug-lovaza-developed-rules-judge/ 2013-09-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstrial-vaccine-monkey-virus-similar-hiv-success/ 2013-09-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroche-partners-inovio-pharma-prostate-cancer-hepatitis-b-therapies/ 2013-09-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-dna-patent-law-what-does-it-mean-pharma/ 2013-09-10T17:45:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-strikes-50m-licensing-deal-with-merck-for-ovarian-cancer-treatment/ 2013-09-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdata-supports-fast-track-approval-roches-breast-cancer-drug-say-fda/ 2013-09-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmelanoma-cancer-vaccine-goes-into-phase-i-clinical-testing/ 2013-09-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-pancreatic-cancer-drug-abraxane/ 2013-09-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-considers-pulling-out-china/ 2013-09-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbayer-seeks-ema-approval-for-marketing-of-regorafenib-to-treat-gist/ 2013-09-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovartis-enters-partnership-develop-stem-cell-technology-kidney-transplant-patients/ 2013-09-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-cancer-vaccine-fails-pass-melanoma-clinical-trial/ 2013-09-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsphase-i-trial-clinical-hiv-vaccine-announced-success/ 2013-09-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgroundbreaking-virus-survey-could-re-focus-pathogen-research/ 2013-09-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newschinese-authorities-claim-gsk-bribery-scandal-co-ordinated-company-level/ 2013-09-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-partnership-develop-immortal-cell-lines-boost-biosimilar-production/ 2013-09-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsema-approves-gsks-melanoma-drug-tafinlar/ 2013-09-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovartis-heart-failure-drug-shows-promise/ 2013-09-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-august-stories-novartis-drug-investigation-amgen-buys-onyx/ 2013-09-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuniversity-warwick-wins-award-outstanding-drug-discovery-capabilities-chagas-disease/ 2013-09-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroches-injectable-herceptin-formula-endorsed-by-eu/ 2013-09-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-investigate-brain-infection-patient-receiving-novartiss-ms-drug/ 2013-08-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsendo-health-solutions-acquires-boca-pharmacal-225-million/ 2021-11-24T05:36:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroche-reports-positive-phase-ii-results-experimental-eye-drug/ 2013-08-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsstrathclyde-scientists-create-drug-detection-computer-programme/ 2013-08-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshighly-specific-new-antibody-introduced-to-boost-her2-type-cancer-research/ 2013-08-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsakorn-inc-purchases-hi-tech-pharmacal-640m/ 2013-08-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscalculator-determines-the-carbon-footprint-of-pharmaceutical-products/ 2013-08-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsamgen-acquires-onyx-pharmaceuticals-for-104bn/ 2013-08-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspharma-companies-pay-150m-to-us-doctors-so-far-this-year/ 2013-08-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsoncomed-granted-us-patent-for-cancer-stem-cell-vaccine/ 2022-02-15T08:08:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-24/ 2023-04-12T06:29:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgastrointestinal-and-liver-breath-test-technology-awarded-patent-in-us/ 2013-08-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscientists-make-breakthrough-in-finding-cure-for-type-of-sleeping-sickness/ 2013-08-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsthalidomide-and-indian-spice-turmeric-combined-can-kill-cancer-cells-say-scientists/ 2013-08-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfalsified-medicines-directive-goes-into-effect-in-the-uk/ 2013-08-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-track-and-trace-new-era-compliance-drug-manufacturers/ 2020-01-31T13:49:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsema-approves-gsks-tyverb-used-in-conjunction-with-herceptin/ 2013-08-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscientists-find-method-to-fight-cancer-by-fortifying-immune-system/ 2013-08-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseli-lilly-in-court-to-defend-alimta-patent/ 2013-08-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-backs-second-gsk-flu-vaccine/ 2013-08-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroche-drops-herceptin-patent-extension-bid-in-india/ 2013-08-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbowel-cancer-may-have-links-to-oral-bacteria/ 2013-08-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsexperimental-eli-lilly-drug-surprises-with-good-results-in-late-stage-study/ 2013-08-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsa-new-gene-study-exposes-the-genesis-of-a-range-of-cancers/ 2013-08-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-virtual-reality-future-science-teaching-pharma-training/ 2013-08-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-breakthrough-breeds-hope-for-worlds-first-dengue-vaccine-candidate/ 2013-08-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsexperimental-breast-cancer-drugs-could-be-used-in-lung-cancer-treatments/ 2013-08-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-gsk-pfizer-hiv-drug-approved-by-fda/ 2013-08-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-compounding-company-recall-medications-after-reports-of-bacterial-infection/ 2013-08-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsskin-cancer-drug-approved-by-uk-regulators/ 2013-08-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-first-rapid-diagnostic-test-both-hiv-1-antigen-hiv-12-antibodies/ 2013-08-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-malaria-vaccine-displays-hopeful-signs-in-early-trials/ 2013-08-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-launches-50m-investment-fund-bioelectronic-medicines-technologies/ 2013-08-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseu-rheumatologists-maintain-trust-pfizers-xeljanz-regardless-chmp-review/ 2013-08-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgrapefruit-lipids-used-create-drug-delivering-nanoparticles/ 2013-08-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsvaleant-pharmaceuticals-to-acquire-bausch-lomb-for-87bn/ 2023-03-20T15:31:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnice-rejects-roches-breast-cancer-drug-perjeta-for-not-being-cost-effective/ 2013-08-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-shipment-of-gsks-four-strain-influenza-vaccine/ 2013-08-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-test-to-predict-death-risk-from-c-diff-developed/ 2013-08-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroches-breast-cancer-drug-patent-partly-annulled-by-indian-government/ 2013-08-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsindia-revokes-gsks-breast-cancer-drug-patent/ 2013-08-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsjohnson-johnson-ordered-to-pay-damages-under-chinas-anti-monopoly-law/ 2013-08-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-july-stories-gsk-bribery-pfizer-marketing-settlement/ 2013-07-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-recalls-nova-blood-glucose-strips/ 2013-07-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-scientists-make-chemotherapy-tolerance-breakthrough-in-mice/ 2013-07-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdiabetes-drug-has-anti-ageing-properties-and-extends-life-of-mice/ 2013-07-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-to-pay-491m-over-illegal-marketing-probe/ 2013-07-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovavax-announces-positive-preclinical-data-for-vaccine-against-influenza/ 2013-07-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsperrigo-buys-elan-corp-for-86bn/ 2013-07-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscertain-blood-pressure-drugs-may-slow-effects-of-alzheimers/ 2013-07-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsresearchers-blood-test-for-alzheimers-very-close/ 2013-07-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-molecule-that-can-suffocate-cancer-cells-discovered/ 2013-07-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshead-of-gsk-china-replaced-amid-corruption-scandal/ 2013-07-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-game-on-joystick-controlled-nano-robots-save-lives/ 2022-02-03T02:29:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-regulator-approves-access-revolade-drug-after-35-year-process/ 2013-07-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroches-profits-climb-10-first-half-year/ 2013-07-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsworlds-only-meningitis-b-vaccine-rejected-by-uk/ 2023-06-30T06:02:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseuropean-and-us-drug-companies-agree-to-share-clinical-studies-researchers/ 2013-07-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbig-pharma-use-patient-groups-oppose-publishing-research-data/ 2013-07-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-doctors-told-to-cut-medicine-waste/ 2013-07-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsstudy-finds-stems-cells-could-cure-blindness/ 2013-07-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstreatment-repair-brain-damage-ms-patients-possible-new-study/ 2013-07-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurescientific-breakthroughs-fight-cure-malaria/ 2021-10-29T05:20:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsphase-iii-prostate-cancer-trial-for-homing-injection-shows-benefit/ 2013-07-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmore-than-200bn-could-be-saved-in-us-by-better-use-drugs-study/ 2013-07-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscientists-develop-cancer-sniffing-knife-to-improve-tumour-removal/ 2013-07-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newschina-bids-tackle-pharma-companies-sale-illegal-medicines/ 2013-07-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsexisting-drugs-other-diseases-could-treat-advanced-ms/ 2013-07-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-executive-confesses-bribery-claims-chinese-tv/ 2013-07-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-first-brain-wave-test-for-adhd-in-children-and-teens/ 2013-07-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newslargest-ever-database-of-genetic-variations-launched/ 2013-07-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-made-illegal-transfers-of-up-to-3bn-yuan-say-chinese-police/ 2013-07-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsunaids-urges-countries-to-scale-up-access-to-antiretroviral-hiv-treatment/ 2013-07-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssixteen-prescription-drugs-made-in-india-recalled-by-uk-watchdog/ 2013-07-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-executives-in-china-have-admitted-to-bribery-say-chinese/ 2013-07-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroche-stops-development-of-diabetes-drug/ 2013-07-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsaids-and-tuberculosis-medicine-shortage-in-india/ 2013-07-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscancer-research-uk-and-forma-therapeutics-announce-research-initiative/ 2013-07-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsleukaemia-treatment-could-effective-common-type-breast-cancer/ 2013-07-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscientists-develop-odour-test-for-bladder-cancer/ 2013-07-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovavax-begins-phase-1-clinical-trial-of-ah7n9-influenza-vaccine/ 2013-07-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-regulator-says-novartiss-breast-cancer-afinitor-drug-not-cost-effective/ 2013-07-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-to-allow-generic-drug-companies-to-update-own-safety-information/ 2013-07-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-anti-cancer-drugs-in-development-inspired-by-leaf-cutter-ants/ 2013-07-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newschina-probes-60-pharma-companies-in-a-bid-to-improve-pricing/ 2013-07-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-doctors-fear-job-losses-government-reshuffles-healthcare-spending/ 2013-07-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseu-manufacturers-threaten-pharma-industry-branded-products-ban/ 2013-07-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstwo-hiv-positive-patients-cleared-of-virus-after-bone-marrow-transplants/ 2013-07-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsefpia-reveals-new-transparency-code/ 2013-07-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newschina-investigates-gsk-for-alleged-bribery/ 2013-07-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-awards-activartis-brain-cancer-drug-orphan-drug-designation/ 2013-07-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-enhances-respiratory-portfolio-pearl-acquisition/ 2013-06-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsks-drisapersen-received-breakthrough-designation-duchenne-muscular-dystrophy-treatment/ 2013-06-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurejunes-top-stories-us-court-against-human-dna-patent-nhs-being-overcharged/ 2013-06-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsglobal-raid-seizes-fake-drugs-worth-40m/ 2013-06-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssanofis-lyxumia-approved-to-treat-diabetes-in-japan/ 2013-06-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroche-astrazeneca-to-share-drug-research-data/ 2013-06-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscelegene-buys-mophosys-for-myeloma-antibody-development/ 2021-11-25T10:57:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmedicines-australia-to-expose-drug-company-handouts-to-doctors/ 2013-06-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstenofovir-cuts-hiv-infection-rates-by-half-in-drug-users/ 2013-06-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newswomen-england-wales-offered-preventative-breast-cancer-drugs/ 2013-06-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastellas-pharma-bags-european-approval-prostate-cancer-drug/ 2013-06-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-fda-seeks-injunction-against-sage-pharmaceuticals/ 2013-06-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssanofis-new-insulin-superior-to-lantus-study/ 2013-06-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspublic-perceptions-clinical-trials-improving-report/ 2013-06-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdrug-companies-chemists-overcharging-nhs/ 2013-06-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-23/ 2023-04-12T06:35:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newslundbeck-drug-makers-fined-euros-pay-delay-deals/ 2013-06-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnaked-mole-rat-unveils-cancer-secrets/ 2013-06-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-investigates-death-of-patients-taking-eli-lilly-antipsychotic-drug/ 2013-06-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsplans-to-ban-pay-to-delay-deals-justified-says-uk-health-economist/ 2013-06-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsjohnson-johnson-to-buy-aragon-pharmaceuticals-for-up-to-1bn/ 2013-06-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-court-rejects-proposed-quick-look-approach-to-generic-pay-to-delay-deals/ 2013-06-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newselan-puts-itself-up-for-sale-invites-royalty-pharma-bid/ 2013-06-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newslondon-university-discovers-vital-clue-to-how-cancer-spreads/ 2013-06-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshuman-dna-cannot-be-patented-us-court-rules/ 2013-06-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-xgeva-to-treat-giant-cell-tumour-of-the-bone/ 2013-06-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsreuters-joins-one-mind-for-research-to-increase-brain-damage-knowledge/ 2021-10-26T06:28:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscancer-drug-could-reduce-need-for-insulin-injections-in-type-1-diabetes-patients/ 2013-06-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurecould-logical-thinking-cure-psychiatric-disease/ 2013-06-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsliver-stem-cell-model-to-speed-up-drug-safety-testing/ 2013-06-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-comprehensive-cancer-database-to-be-launched/ 2013-06-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssanofis-four-strain-flu-vaccine-gets-fda-approval/ 2013-06-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-buys-pearl-therapeutics-in-115bn-deal/ 2013-06-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsresearchers-uncover-cancer-genes-that-help-melanoma-spread/ 2013-06-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdysfunctions-in-arc-protein-may-be-key-to-memory-loss-scientists-say/ 2013-06-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovavax-produces-vaccine-for-newly-emerging-middle-east-virus/ 2013-06-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-votes-to-ease-restrictions-on-gsks-avandia/ 2013-06-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscientists-reveal-malarias-deadly-binding-mechanism/ 2013-06-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsexperimental-multiple-sclerosis-trial-deemed-safe/ 2013-06-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-data-shows-novartis-ms-drug-improves-four-key-symptoms-of-disease/ 2013-06-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsresearchers-identify-new-possible-treatment-pathway-for-brain-cancer/ 2013-06-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-house-approves-pharma-security-bill/ 2013-06-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmalaria-breakthrough-triggers-hope-for-new-vaccine/ 2013-06-03T17:30:00+00:00 daily 0.2